DOCOMO and Ubie Form Strategic Capital and Business Alliance
NTT DOCOMO, INC., led by Representative Director and President Yoshiaki Maeda, is based in Chiyoda-ku, Tokyo. Ubie Inc. is also part of this discussion. Ubie, based in Chuo-ku, Tokyo, has formed a capital and business alliance. The Co-Representative Directors are Yoshitomo Abe and Kota Kubo. This agreement helps people live longer and healthier. It does this by sharing personalized medical and health information with more individuals. DOCOMO signed the agreement on Friday, March 14, 2025. Then, it finalized its investment in Ubie on Thursday, March 27, 2025. As part of this alliance, DOCOMO’s “d ACCOUNT®” will be integrated with Ubie’s symptom checker platform, enabling tailored medical and health-related service information to be provided to individual users. Partnership Objectives DOCOMO, with over 100 million d ACCOUNT users, has been actively supporting…
Just for You
Otsuka Shokai provides operational support services for the EDR product “Microsoft Defender for Business”
Otsuka Shokai Co. Ltd. announced that it will start offering "Tayoreru EDR Advisory Service for…
Telexistence Inc. Joined the AI Robot Association together with Toyota Motor Corporation and others to promote the construction of the VLA model
Telexistence Inc. has joined the AI Robot Association as a board member and has begun…
ITBusinessToday Weekly News Roundup With Plus, ServiceNow, Chubu Electric Power, Rakus, NetOns & Airx and More!
In GovTech news this week… 🔹 Plus and TIER IV Partner to Advance Autonomy 2.0…
AWS Unveils “Ocelot” Quantum Chip, Advancing Error Correction with Analog Cat Qubits
Amazon Web Services (AWS) has launched its new quantum computing chip, "Ocelot." This move puts…
Latest Health Tech
NEC and biomy partner to develop and expand analysis platform in the digital pathology field
NEC Corporation (hereinafter referred to as NEC) and biomy, Inc. (hereinafter referred to as biomy) have signed a memorandum of…
Primo Partners with SHINE to Advance Precision Oncology in Asia Pacific
Primo Biotechnology ("Primo") has announced a strategic collaboration with SHINE Technologies ("Shine"), a global leader in nuclear medicine manufacturing. The…
CN Bio Partners with Primetech to Establish Distribution Channel for OOC Solutions in Japan
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, announced it…
Daiichi Sankyo Acquires Anti-TA-MUC1 Antibody IP from Glycotope
Daiichi Sankyo Company, Ltd announced that it will pay Glycotope $132.5 million to acquire intellectual property rights of the anti-tumor-associated…